{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:41:16Z","timestamp":1787582476664,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100006356","name":"University of Southern Denmark","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006356","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-026-02358-z","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T14:47:25Z","timestamp":1781534845000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["COVID-19 infection prior to the onset of type 1 diabetes does not impair beta-cell function: a two-year nationwide follow-up study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4128-5714","authenticated-orcid":false,"given":"Morten","family":"Bjerregaard-Andersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pernille Emilie","family":"Hostrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristoffer Jensen","family":"Kolnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maj","family":"Bangshaab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alin Razvan","family":"Andries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troels Krarup","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vestergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flemming","family":"Pociot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"H\u00f8jlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus Bogh","family":"Juhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"2358_CR1","unstructured":"World Health Organization. Coronavirus disease (COVID-19) pandemic. 2025."},{"issue":"9","key":"2358_CR2","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1007\/s11606-024-09254-z","volume":"40","author":"I Ivlev","year":"2025","unstructured":"Ivlev I, Wagner J, Phillips T, Treadwell JR. Interventions for Long COVID: A Narrative Review. J Gen Intern Med. 2025;40(9):2005\u201323.","journal-title":"J Gen Intern Med"},{"issue":"1","key":"2358_CR3","doi-asserted-by":"publisher","first-page":"5663","DOI":"10.1038\/s41467-022-33415-5","volume":"13","author":"CE Hastie","year":"2022","unstructured":"Hastie CE, Lowe DJ, McAuley A, Winter AJ, Mills NL, Black C, Scott JT, O\u2019Donnell CA, Blane DN, Browne S, et al. Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study. Nat Commun. 2022;13(1):5663.","journal-title":"Nat Commun"},{"issue":"5","key":"2358_CR4","doi-asserted-by":"publisher","first-page":"703","DOI":"10.7326\/M21-0367","volume":"174","author":"JM Gregory","year":"2021","unstructured":"Gregory JM, Moore DJ. The Dual Burden of Type 1 Diabetes and COVID-19. Ann Intern Med. 2021;174(5):703\u20134.","journal-title":"Ann Intern Med"},{"issue":"2","key":"2358_CR5","doi-asserted-by":"publisher","first-page":"e936","DOI":"10.1210\/clinem\/dgaa825","volume":"106","author":"G O\u2019Malley","year":"2021","unstructured":"O\u2019Malley G, Ebekozien O, Desimone M, Pinnaro CT, Roberts A, Polsky S, Noor N, Aleppo G, Basina M, Tansey M, et al. COVID-19 Hospitalization in Adults with Type 1 Diabetes: Results from the T1D Exchange Multicenter Surveillance Study. J Clin Endocrinol Metab. 2021;106(2):e936\u201342.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2358_CR6","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/j.cgh.2020.04.040","volume":"18","author":"F Liu","year":"2020","unstructured":"Liu F, Long X, Zhang B, Zhang W, Chen X, Zhang Z. ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection. Clin Gastroenterol Hepatol. 2020;18(9):2128\u201330. e2122.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"2358_CR7","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.cmet.2021.05.013","volume":"33","author":"CT Wu","year":"2021","unstructured":"Wu CT, Lidsky PV, Xiao Y, Lee IT, Cheng R, Nakayama T, Jiang S, Demeter J, Bevacqua RJ, Chang CA, et al. SARS-CoV-2 infects human pancreatic beta cells and elicits beta cell impairment. Cell Metab. 2021;33(8):1565\u2013e15761565.","journal-title":"Cell Metab"},{"issue":"12","key":"2358_CR8","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1001\/jama.2023.16348","volume":"330","author":"M Lugar","year":"2023","unstructured":"Lugar M, Eugster A, Achenbach P, von dem Berge T, Berner R, Besser REJ, Casteels K, Elding Larsson H, Gemulla G, Kordonouri O, et al. SARS-CoV-2 Infection and Development of Islet Autoimmunity in Early Childhood. JAMA. 2023;330(12):1151\u201360.","journal-title":"JAMA"},{"key":"2358_CR9","doi-asserted-by":"publisher","first-page":"155330","DOI":"10.1016\/j.metabol.2022.155330","volume":"137","author":"H Lai","year":"2022","unstructured":"Lai H, Yang M, Sun M, Pan B, Wang Q, Wang J, Tian J, Ding G, Yang K, Song X, et al. Risk of incident diabetes after COVID-19 infection: A systematic review and meta-analysis. Metabolism. 2022;137:155330.","journal-title":"Metabolism"},{"issue":"2","key":"2358_CR10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.15585\/mmwr.mm7102e2","volume":"71","author":"CE Barrett","year":"2022","unstructured":"Barrett CE, Koyama AK, Alvarez P, Chow W, Lundeen EA, Perrine CG, Pavkov ME, Rolka DB, Wiltz JL, Bull-Otterson L, et al. Risk for Newly Diagnosed Diabetes\u2009>\u200930 Days After SARS-CoV-2 Infection Among Persons Aged\u2009<\u200918 Years - United States, March 1, 2020-June 28, 2021. MMWR Morb Mortal Wkly Rep. 2022;71(2):59\u201365.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"11","key":"2358_CR11","doi-asserted-by":"publisher","first-page":"5112","DOI":"10.1002\/jmv.27996","volume":"94","author":"M Rahmati","year":"2022","unstructured":"Rahmati M, Keshvari M, Mirnasuri S, Yon DK, Lee SW, Il Shin J, Smith L. The global impact of COVID-19 pandemic on the incidence of pediatric new-onset type 1 diabetes and ketoacidosis: A systematic review and meta-analysis. J Med Virol. 2022;94(11):5112\u201327.","journal-title":"J Med Virol"},{"issue":"6","key":"2358_CR12","doi-asserted-by":"publisher","first-page":"e2321281","DOI":"10.1001\/jamanetworkopen.2023.21281","volume":"6","author":"D D\u2019Souza","year":"2023","unstructured":"D\u2019Souza D, Empringham J, Pechlivanoglou P, Uleryk EM, Cohen E, Shulman R. Incidence of Diabetes in Children and Adolescents During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2023;6(6):e2321281.","journal-title":"JAMA Netw Open"},{"issue":"5","key":"2358_CR13","doi-asserted-by":"publisher","first-page":"921","DOI":"10.2337\/dc22-0385","volume":"46","author":"PM McKeigue","year":"2023","unstructured":"McKeigue PM, McGurnaghan S, Blackbourn L, Bath LE, McAllister DA, Caparrotta TM, Wild SH, Wood SN, Stockton D, Colhoun HM. Relation of Incident Type 1 Diabetes to Recent COVID-19 Infection: Cohort Study Using e-Health Record Linkage in Scotland. Diabetes Care. 2023;46(5):921\u20138.","journal-title":"Diabetes Care"},{"issue":"6","key":"2358_CR14","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.2337\/dc22-2351","volume":"46","author":"R Noorzae","year":"2023","unstructured":"Noorzae R, Junker TG, Hviid AP, Wohlfahrt J, Olsen SF. Risk of Type 1 Diabetes in Children Is Not Increased After SARS-CoV-2 Infection: A Nationwide Prospective Study in Denmark. Diabetes Care. 2023;46(6):1261\u20134.","journal-title":"Diabetes Care"},{"issue":"8","key":"2358_CR15","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.2337\/dc23-0428","volume":"46","author":"B Zareini","year":"2023","unstructured":"Zareini B, Sorensen KK, Eiken PA, Fischer TK, Kristensen PL, Lendorf ME, Pedersen-Bjergaard U, Torp-Pedersen C, Nolsoe RLM. Association of COVID-19 and Development of Type 1 Diabetes: A Danish Nationwide Register Study. Diabetes Care. 2023;46(8):1477\u201382.","journal-title":"Diabetes Care"},{"issue":"11","key":"2358_CR16","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.2337\/dc22-0278","volume":"45","author":"F Reschke","year":"2022","unstructured":"Reschke F, Lanzinger S, Herczeg V, Prahalad P, Schiaffini R, Mul D, Clapin H, Zabeen B, Pelicand J, Phillip M, et al. The COVID-19 Pandemic Affects Seasonality, With Increasing Cases of New-Onset Type 1 Diabetes in Children, From the Worldwide SWEET Registry. Diabetes Care. 2022;45(11):2594\u2013601.","journal-title":"Diabetes Care"},{"key":"2358_CR17","doi-asserted-by":"publisher","first-page":"1287354","DOI":"10.3389\/fendo.2023.1287354","volume":"14","author":"J Rosenbauer","year":"2023","unstructured":"Rosenbauer J, Stahl-Pehe A, Baechle C, Lanzinger S, Kamrath C, Kuss O, Holl RW. Spatiotemporal association between COVID-19 incidence and type 1 diabetes incidence among children and adolescents: a register-based ecological study in Germany. Front Endocrinol (Lausanne). 2023;14:1287354.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2358_CR18","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/s41598-024-84654-z","volume":"15","author":"T Saito","year":"2025","unstructured":"Saito T, Mochizuki M, Kobayashi K, Narusawa H, Watanabe D, Makino K, Yagasaki H, Sato K, Sano T, Ohta M, et al. Impact of the severe acute respiratory syndrome coronavirus 2 pandemic on the incidence of type 1 diabetes mellitus in children in Yamanashi, Japan. Sci Rep. 2025;15(1):484.","journal-title":"Sci Rep"},{"issue":"10","key":"2358_CR19","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1007\/s00592-023-02103-1","volume":"60","author":"C Tiberti","year":"2023","unstructured":"Tiberti C, Nenna R, Tromba V, Filardi T, Petrarca L, Silvestri F, Fassino V, Montuori M, Mancino E, Lenzi A, et al. No effects of COVID-19 on the development of type 1 diabetes autoimmunity and no evidence of an increased frequency of SARS-CoV-2 antibodies in newly diagnosed type 1 diabetes patients relative to healthy subjects. Acta Diabetol. 2023;60(10):1301\u20137.","journal-title":"Acta Diabetol"},{"issue":"4","key":"2358_CR20","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S2213-8587(23)00041-4","volume":"11","author":"M Knip","year":"2023","unstructured":"Knip M, Parviainen A, Turtinen M, But A, Harkonen T, Hepojoki J, Sironen T, Iheozor-Ejiofor R, Ugurlu H, Saksela K, et al. SARS-CoV-2 and type 1 diabetes in children in Finland: an observational study. Lancet Diabetes Endocrinol. 2023;11(4):251\u201360.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2358_CR21","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12902-024-01667-5","volume":"24","author":"M Bjerregaard-Andersen","year":"2024","unstructured":"Bjerregaard-Andersen M, Da Silva J, Diogo R, Claro AR, Ferro I, Romana A, Rocha P, Sa B, Lobarinhas G, Rolim S, et al. Association between COVID-19 and the incidence of type 1 diabetes in Portugal - a registry study. BMC Endocr Disord. 2024;24(1):145.","journal-title":"BMC Endocr Disord"},{"issue":"4","key":"2358_CR22","doi-asserted-by":"publisher","first-page":"763","DOI":"10.4093\/dmj.2023.0175","volume":"48","author":"DTW Lui","year":"2024","unstructured":"Lui DTW, Lee CH, Wong Y, Fong CHY, Tsoi KH, Woo YC, Tan KCB. A Prospective 1-Year Follow-up of Glycemic Status and C-Peptide Levels of COVID-19 Survivors with Dysglycemia in Acute COVID-19 Infection. Diabetes Metab J. 2024;48(4):763\u201370.","journal-title":"Diabetes Metab J"},{"key":"2358_CR23","doi-asserted-by":"crossref","unstructured":"Sorensen JS, Johannesen J, Pociot F, Kristensen K, Thomsen J, Hertel NT, Kjaersgaard P, Brorsson C, Birkebaek NH, et al. Danish society for diabetes in C : residual beta-cell function 3\u20136 years after onset of type 1 diabetes reduces risk of severe hypoglycemia in children and adolescents. Diabetes Care. 2013;36(11):3454\u20133459.","DOI":"10.2337\/dc13-0418"},{"issue":"4","key":"2358_CR24","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1111\/jdi.12763","volume":"9","author":"S Uno","year":"2018","unstructured":"Uno S, Imagawa A, Kozawa J, Fukui K, Iwahashi H, Shimomura I. Complete loss of insulin secretion capacity in type 1A diabetes patients during long-term follow up. J Diabetes Investig. 2018;9(4):806\u201312.","journal-title":"J Diabetes Investig"},{"issue":"3","key":"2358_CR25","doi-asserted-by":"publisher","first-page":"476","DOI":"10.2337\/dc14-1952","volume":"38","author":"AK Davis","year":"2015","unstructured":"Davis AK, DuBose SN, Haller MJ, Miller KM, DiMeglio LA, Bethin KE, Goland RS, Greenberg EM, Liljenquist DR, Ahmann AJ, et al. Prevalence of detectable C-Peptide according to age at diagnosis and duration of type 1 diabetes. Diabetes Care. 2015;38(3):476\u201381.","journal-title":"Diabetes Care"},{"key":"2358_CR26","doi-asserted-by":"crossref","unstructured":"Greenbaum CJ, Mandrup-Poulsen T, McGee PF, Battelino T, Haastert B, Ludvigsson J, Pozzilli P, Lachin JM, Kolb H, Type 1 Diabetes Trial Net Research G. Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes. Diabetes Care. 2008;31(10):1966\u201371.","DOI":"10.2337\/dc07-2451"},{"issue":"7\u20138","key":"2358_CR27","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.clinbiochem.2016.12.004","volume":"50","author":"PB Larsen","year":"2017","unstructured":"Larsen PB, Linneberg A, Hansen T, Friis-Hansen L. Reference intervals for C-peptide and insulin derived from a general adult Danish population. Clin Biochem. 2017;50(7\u20138):408\u201313.","journal-title":"Clin Biochem"},{"issue":"2","key":"2358_CR28","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2337\/dc12-0836","volume":"36","author":"RE Besser","year":"2013","unstructured":"Besser RE, Shields BM, Casas R, Hattersley AT, Ludvigsson J. Lessons from the mixed-meal tolerance test: use of 90-minute and fasting C-peptide in pediatric diabetes. Diabetes Care. 2013;36(2):195\u2013201.","journal-title":"Diabetes Care"},{"key":"2358_CR29","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2147\/IDR.S383491","volume":"16","author":"LW Krogsgaard","year":"2023","unstructured":"Krogsgaard LW, Espenhain L, Tribler S, Svaerke Jorgensen C, Hansen CH, Moller FT, Glode Helmuth I, Sonksen UW, Vangsted AM, Ullum H, et al. Seroprevalence of SARS-CoV-2 Antibodies in Denmark: Results of Two Nationwide Population-Based Surveys, February and May 2021. Infect Drug Resist. 2023;16:301\u201312.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"2358_CR30","doi-asserted-by":"publisher","first-page":"e0417422","DOI":"10.1128\/spectrum.04174-22","volume":"11","author":"K Fogh","year":"2023","unstructured":"Fogh K, Eriksen ARR, Larsen TG, Hasselbalch RB, Bundgaard H, Scharff B, Nielsen SD, Jorgensen CS, Erikstrup C, Ostergaard L, et al. A Cross-Sectional Study of SARS-CoV-2 Antibodies and Risk Factors for Seropositivity in Staff in Day Care Facilities and Preschools in Denmark. Microbiol Spectr. 2023;11(1):e0417422.","journal-title":"Microbiol Spectr"},{"issue":"1","key":"2358_CR31","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12879-022-07102-1","volume":"22","author":"K Fogh","year":"2022","unstructured":"Fogh K, Eriksen ARR, Hasselbalch RB, Kristensen ES, Bundgaard H, Nielsen SD, Jorgensen CS, Scharff B, Erikstrup C, Saekmose SG, et al. Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark. BMC Infect Dis. 2022;22(1):143.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"2358_CR32","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.ecl.2010.05.011","volume":"39","author":"DM Maahs","year":"2010","unstructured":"Maahs DM, West NA, Lawrence JM, Mayer-Davis EJ. Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am. 2010;39(3):481\u201397.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2358_CR33","doi-asserted-by":"crossref","unstructured":"Karaoglan M, Eksi F. The coincidence of newly diagnosed type 1 diabetes mellitus with IgM antibody positivity to enteroviruses and respiratory tract viruses. J Diabetes Res. 2018;2018:8475341.","DOI":"10.1155\/2018\/8475341"},{"issue":"11","key":"2358_CR34","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.2337\/db07-1023","volume":"57","author":"CM Filippi","year":"2008","unstructured":"Filippi CM, von Herrath MG. Viral trigger for type 1 diabetes: pros and cons. Diabetes. 2008;57(11):2863\u201371.","journal-title":"Diabetes"},{"issue":"10","key":"2358_CR35","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.autrev.2016.07.019","volume":"15","author":"T Rodriguez-Calvo","year":"2016","unstructured":"Rodriguez-Calvo T, Sabouri S, Anquetil F, von Herrath MG. The viral paradigm in type 1 diabetes: Who are the main suspects? Autoimmun Rev. 2016;15(10):964\u20139.","journal-title":"Autoimmun Rev"},{"issue":"11","key":"2358_CR36","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1038\/s41591-023-02576-1","volume":"29","author":"L Krogvold","year":"2023","unstructured":"Krogvold L, Mynarek IM, Ponzi E, Mork FB, Hessel TW, Roald T, Lindblom N, Westman J, Barker P, Hyoty H, et al. Pleconaril and ribavirin in new-onset type 1 diabetes: a phase 2 randomized trial. Nat Med. 2023;29(11):2902\u20138.","journal-title":"Nat Med"},{"issue":"1","key":"2358_CR37","doi-asserted-by":"publisher","first-page":"4541","DOI":"10.1038\/s41467-020-18319-6","volume":"11","author":"J Yang","year":"2020","unstructured":"Yang J, Petitjean SJL, Koehler M, Zhang Q, Dumitru AC, Chen W, Derclaye S, Vincent SP, Soumillion P, Alsteens D. Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor. Nat Commun. 2020;11(1):4541.","journal-title":"Nat Commun"},{"issue":"6","key":"2358_CR38","doi-asserted-by":"publisher","first-page":"e70084","DOI":"10.1002\/dmrr.70084","volume":"41","author":"S Tall","year":"2025","unstructured":"Tall S, Prahalad P, Adiels M, Rosengren A, Virtanen SM, Maahs DM, Knip M. Increased Risk of Type 1 Diabetes in Boys Under the Age of 5 Years During COVID-19 Lockdowns in Finland, Sweden and Stanford, CA, USA-An Observational Multicenter Study. Diabetes Metab Res Rev. 2025;41(6):e70084.","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"2358_CR39","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s13340-015-0211-5","volume":"7","author":"S Tanaka","year":"2016","unstructured":"Tanaka S, Okubo M, Nagasawa K, Takizawa S, Ichijo M, Ichijo S, Kaneshige M, Aida K, Shimura H, Mori Y, et al. Predictive value of titer of GAD antibodies for further progression of beta cell dysfunction in slowly progressive insulin-dependent (type 1) diabetes (SPIDDM). Diabetol Int. 2016;7(1):42\u201352.","journal-title":"Diabetol Int"},{"issue":"2","key":"2358_CR40","doi-asserted-by":"publisher","first-page":"e3770","DOI":"10.1002\/dmrr.3770","volume":"40","author":"CS Weston","year":"2024","unstructured":"Weston CS, Boehm BO, Pozzilli P. Type 1 diabetes: A new vision of the disease based on endotypes. Diabetes Metab Res Rev. 2024;40(2):e3770.","journal-title":"Diabetes Metab Res Rev"},{"key":"2358_CR41","doi-asserted-by":"crossref","unstructured":"Hamady A, Lee J, Loboda ZA. Waning antibody responses in COVID-19: What can we learn from the analysis of other coronaviruses? Infection. 2022;50(1):11\u201325.","DOI":"10.1007\/s15010-021-01664-z"},{"key":"2358_CR42","unstructured":"World Health Organization. Tracking SARS-CoV-2 variants. 2025."},{"issue":"1","key":"2358_CR43","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41387-023-00241-7","volume":"13","author":"J Gojda","year":"2023","unstructured":"Gojda J, Koudelkova K, Ouradova A, Lang A, Krbcova M, Gvozdeva A, Sebo V, Slagmolen L, Potockova J, Tuma P, et al. Severe COVID-19 associated hyperglycemia is caused by beta cell dysfunction: a prospective cohort study. Nutr Diabetes. 2023;13(1):11.","journal-title":"Nutr Diabetes"},{"issue":"1","key":"2358_CR44","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00125-024-06290-6","volume":"68","author":"PE Hostrup","year":"2025","unstructured":"Hostrup PE, Schmidt T, Hellsten SB, Gerwig RH, Storling J, Johannesen J, Sulek K, Hostrup M, Andersen HU, Buschard K, et al. Effect of fenofibrate on residual beta cell function in adults and adolescents with newly diagnosed type 1 diabetes: a randomised clinical trial. Diabetologia. 2025;68(1):29\u201340.","journal-title":"Diabetologia"},{"key":"2358_CR45","doi-asserted-by":"publisher","first-page":"111206","DOI":"10.1016\/j.jpsychores.2023.111206","volume":"168","author":"A Troncone","year":"2023","unstructured":"Troncone A, Cascella C, Chianese A, Zanfardino A, Pizzini B, Iafusco D. Psychological consequences of the COVID-19 pandemic in people with type 1 diabetes: A systematic literature review. J Psychosom Res. 2023;168:111206.","journal-title":"J Psychosom Res"},{"issue":"1","key":"2358_CR46","doi-asserted-by":"publisher","first-page":"16021","DOI":"10.1038\/s41598-025-99280-6","volume":"15","author":"JM Cho","year":"2025","unstructured":"Cho JM, Oh JI, Koh JH, Kim M, Kim SG, Cho S, Lee S, Kim Y, Kim YC, Han SS, et al. New-onset mental disorders increase among patients with metabolic diseases after the COVID-19 pandemic. Sci Rep. 2025;15(1):16021.","journal-title":"Sci Rep"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02358-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02358-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02358-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:03:14Z","timestamp":1787580194000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02358-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2358"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02358-z","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"18 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study received ethical approval by the Regional Committees on Health Research Ethics for Southern Denmark on the 23rd of October 2020 (reference S-20200119), with an amendment (reference 91017) approved on the 17th of June 2022. It was registered at ClinicalTrials.gov (NCT04623697), on November the 10th, 2020. The study was conducted according to the Helsinki Declaration and Good Clinical Practices guidelines. All participants received oral and written information regarding the study and provided individual written informed consent.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided individual informed consent, including for publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"244"}}